Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,340.01
(
0.43%
)
News Focus
News Focus
Post# of 448084
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Biobillionair

Send PM Follow Ignore
Followers 232
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Biobillionair

Re: jessellivermore post# 184963

Tuesday, 04/02/2019 9:52:26 AM

Tuesday, April 02, 2019 9:52:26 AM

Post# of 448084
Can you share your opinion on SOC and malpractice? Where does this NOW leave the FDA? I haven't had the time to think about this recently, but I believe the FDA is in theoretical legal jeopardy if they can't claim sovereign immunity. I would think from a Constitutional standpoint the sovereign immunity is breached by 5th and 14th Amendments.

Patients refused a prescriptions based on FDA labeling and SOC differences may NOW have legal recourse against the US Government if they are diabetic and have an event.

Any thoughts?

BB

I do not pump Amarin stock. I am not an Amarin cheerleader. If I see something I don't like I make it known. Patients come first, always!!!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News